Equity capital markets - healthcare: Q1 2022 review
Issuers, for the most part, were willing to sit this quarter out, say Kevin Davies and Stephen Roney, Healthcare Investment & Corporate Banking. They provide a detailed look at the healthcare market’s rough Q1, and advice for issuers on the path forward.